For a patient with type 2 diabetes receiving dexamethasone 4 mg at 8 am and 4 mg at 8 pm, and NPH insulin 20 U at 8 am and 20 U at 8 pm (insulin‑to‑carbohydrate ratio 1 U per 8 g carbohydrate, insulin sensitivity factor 25 mg/dL per unit), if the morning dexamethasone dose is reduced, what should the 8 am NPH insulin dose be and should the 8 pm NPH insulin dose be changed?

NPH Insulin Dose Adjustment for Steroid Taper in Type 2 Diabetes

When reducing dexamethasone from twice-daily (8 am and 8 pm) to once-daily (8 am only) dosing, decrease the 8 pm NPH insulin dose by 50% (from 20 units to 10 units) and maintain the 8 am NPH dose at 20 units initially, then titrate based on glucose monitoring.

Understanding Steroid-Induced Hyperglycemia Patterns

Dexamethasone causes a characteristic hyperglycemic pattern that peaks 4-6 hours after administration and persists throughout the day 1. When given in the morning, the most pronounced hyperglycemia occurs in the afternoon and evening, with relatively normal or mildly elevated fasting glucose 2. This is critical to understand when adjusting insulin.

Specific Dosing Recommendations

Morning NPH (8 am dose):

• Keep at 20 units initially
• This dose covers the hyperglycemic effect of the morning dexamethasone 4 mg
• The 2025 ADA Standards specifically recommend "dosing NPH in the morning for steroid-induced hyperglycemia" 1
• Monitor afternoon and evening glucose levels closely, as these will be most affected by the morning dexamethasone

Evening NPH (8 pm dose):

• Reduce to 10 units (50% reduction)
• You are eliminating the evening dexamethasone dose, which was driving the overnight and morning hyperglycemia
• Without the evening steroid, the full 20 units of evening NPH creates significant hypoglycemia risk
• A 50% reduction is a conservative starting point that balances glycemic control with hypoglycemia prevention

Rationale for This Approach

The evidence shows that steroid-induced hyperglycemia follows the pharmacokinetic profile of the steroid 2. When you eliminate the evening dexamethasone:

• Overnight insulin requirements drop substantially because there's no steroid effect to counteract
• Morning fasting glucose should improve without evening steroid exposure
• Daytime hyperglycemia persists due to the morning dexamethasone dose

Research demonstrates that dexamethasone causes blood glucose to approximately double within 6 hours of administration 3. Removing one of two daily doses eliminates roughly half of the total steroid burden, but the timing matters more than the total dose.

Titration Strategy

After making these initial adjustments, use the following algorithm 1:

For the 8 am NPH dose:

• Check pre-lunch and pre-dinner glucose
• If consistently >180 mg/dL: increase by 2 units every 2-3 days
• If hypoglycemia occurs (<70 mg/dL): decrease by 10-20%

For the 8 pm NPH dose:

• Check fasting glucose (before 8 am dose)
• If consistently >180 mg/dL: increase by 1-2 units every 2-3 days
• If hypoglycemia occurs: decrease by 10-20%
• May need to reduce further or discontinue if fasting glucose normalizes

Critical Monitoring Points

Monitor glucose at these specific times to guide adjustments:

• Fasting (pre-breakfast): Reflects evening NPH adequacy
• Pre-lunch: Reflects morning NPH and morning dexamethasone effect
• Pre-dinner: Peak effect of morning dexamethasone and morning NPH
• Bedtime: Determines safety of evening NPH dose

Common Pitfalls to Avoid

1. Don't maintain the full evening NPH dose - This is the most dangerous error. Without evening dexamethasone, 20 units of NPH will likely cause nocturnal hypoglycemia.

2. Don't reduce the morning NPH proportionally - The morning dexamethasone 4 mg still requires substantial insulin coverage. The morning NPH must address the full hyperglycemic effect of this dose.

3. Don't wait too long to titrate - Reassess doses every 2-3 days based on glucose patterns 1. Therapeutic inertia leads to prolonged hyperglycemia.

4. Don't forget the correction insulin - Your ICR (1:8) and ISF (1:25) remain important for meal coverage and corrections. These parameters don't change with the steroid taper.

Alternative Consideration

If hypoglycemia becomes problematic with the evening NPH, consider switching the evening dose to a long-acting basal analog (glargine or degludec) given in the morning instead 1. This provides more stable basal coverage without the pronounced peak that NPH creates overnight when steroid effect is absent. However, this increases cost and complexity.

The key principle: Match insulin timing and intensity to steroid timing and intensity. Removing evening dexamethasone eliminates the need for aggressive evening/overnight insulin coverage while maintaining the need for robust daytime coverage.